Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-30 | New | $20,119,049 | $20,119,049 | Equity Only | 06b | SEC link |
| 2024-10-15 | New | $12,379,983 | $12,379,983 | Equity Only | 06c | SEC link |
| 2023-12-28 | New | $14,425,013 | $14,425,013 | Equity Only | 06b | SEC link |
| 2020-09-04 | Amended | $34,980,581 | $26,168,425 | Equity Only | 06b | SEC link |
| 2018-09-20 | Amended | $8,812,156 | $4,054,626 | Equity Only | 06b | SEC link |
| 2018-05-22 | New | $4,757,530 | $4,757,530 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Melissa Beelen | Executive |
| Peter Brandt | Director |
| Thomas Cirrito | Director |
| Corinne Epperly | Director |
| Emily R. Fairbairn | Director |
| Trishna Goswami | Executive |
| Jeremy Graff | Director |
| Luba Greenwood | Director |
| William Ho | Director, Executive |
| Larry Lamb | Executive |
| Lawrence Lamb | Executive |
| Patrick Mc Call | Executive |
| Kate Rochlin | Executive |
| Alan S. Roemer | Director |
| Travis Whitfill | Director |